298 related articles for article (PubMed ID: 21540420)
21. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries.
Matlock DD; Groeneveld PW; Sidney S; Shetterly S; Goodrich G; Glenn K; Xu S; Yang L; Farmer SA; Reynolds K; Cassidy-Bushrow AE; Lieu T; Boudreau DM; Greenlee RT; Tom J; Vupputuri S; Adams KF; Smith DH; Gunter MJ; Go AS; Magid DJ
JAMA; 2013 Jul; 310(2):155-62. PubMed ID: 23839749
[TBL] [Abstract][Full Text] [Related]
22. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
[TBL] [Abstract][Full Text] [Related]
23. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
[TBL] [Abstract][Full Text] [Related]
24. Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012.
Culler SD; Kugelmass AD; Brown PP; Reynolds MR; Simon AW
Circulation; 2015 Jan; 131(4):362-70; discussion 370. PubMed ID: 25533970
[TBL] [Abstract][Full Text] [Related]
25. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
26. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
Huang HW; Brent BN; Shaw RE
Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
[TBL] [Abstract][Full Text] [Related]
27. Rates of revascularization and PCI:CABG ratio: a new indicator predicting in-hospital mortality in acute coronary syndromes.
Klein LW; Abugroun A; Daoud H
Coron Artery Dis; 2022 Mar; 33(2):69-74. PubMed ID: 34074913
[TBL] [Abstract][Full Text] [Related]
28. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
29. Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
Jones WS; Patel MR; Holleran SA; Harrison JK; O'Connor CM; Phillips HR
Am Heart J; 2011 Nov; 162(5):932-7. PubMed ID: 22093211
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug-Eluting Stents in Older Adults.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
J Am Geriatr Soc; 2017 Mar; 65(3):625-630. PubMed ID: 28165613
[TBL] [Abstract][Full Text] [Related]
32. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
[TBL] [Abstract][Full Text] [Related]
33. Trends and outcomes of concurrent carotid revascularization and coronary bypass.
Timaran CH; Rosero EB; Smith ST; Valentine RJ; Modrall JG; Clagett GP
J Vasc Surg; 2008 Aug; 48(2):355-360; discussion 360-1. PubMed ID: 18572353
[TBL] [Abstract][Full Text] [Related]
34. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
Yamamoto K; Shiomi H; Morimoto T; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Natsuaki M; Yamaji K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
Am J Cardiol; 2021 Apr; 145():47-57. PubMed ID: 33454345
[TBL] [Abstract][Full Text] [Related]
36. Adverse events after coronary revascularization procedures in California 2000 to 2010.
Rudersdorf PD; Abolhoda A; Carey JS; Danielsen B; Milliken JC
Am J Cardiol; 2013 Aug; 112(4):483-7. PubMed ID: 23668638
[TBL] [Abstract][Full Text] [Related]
37. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
[TBL] [Abstract][Full Text] [Related]
38. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
39. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial.
Magnuson EA; Chinnakondepalli K; Vilain K; Serruys PW; Sabik JF; Kappetein AP; Stone GW; Cohen DJ;
Circ Cardiovasc Interv; 2022 Jul; 15(7):e011981. PubMed ID: 35861797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
